HBV induced carcinogenesis (Q36388400)

13 August 2017

1 reference

title

HBV induced carcinogenesis (English)

1 reference

13 August 2017

1 reference

Delphine Cougot

1

1 reference

PubMed ID

16461228

13 August 2017

Christine Neuveut

series ordinal

2

1 reference

PubMed ID

16461228

13 August 2017

Marie Annick Buendia

series ordinal

3

1 reference

13 August 2017

1 December 2005

1 reference

Journal of Clinical Virology

13 August 2017

1 reference

13 August 2017

34 Suppl 1

1 reference

13 August 2017

S75-8

1 reference

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Molecular viral oncology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B viruses and cancerogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Genetics of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

At the crossroads of inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B virus X protein: structure, function and biology.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Immune pathogenesis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B virus genotypes and hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

TP53 and liver carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980014-9

7 January 2021

10.1016/S1386-6532(05)80014-9

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16461228